Health ❯ Healthcare ❯ Medical Research ❯ Oncology

Bladder Cancer

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial

Regulators will now evaluate linking immunotherapy use to a ctDNA companion test.

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer